Last reviewed · How we verify

NCT04982419: RICH

Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial

Recruiting now Phase 2, PHASE3 Last updated 15 December 2025
What this trial tests

Phase 2, PHASE3 trial testing Remote ischemic preconditioning in Acute Kidney Injury in 240 participants. Currently enrolling.

Timeline
1 November 2021
Primary endpoint
31 March 2028
31 March 2029

Quick facts

Lead sponsorVA Office of Research and Development
PhasePhase 2, PHASE3
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment240
Start date1 November 2021
Primary completion31 March 2028
Estimated completion31 March 2029
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

VA Office of Research and Development — full company profile →

Who can join

18 and older, any sex, with Acute Kidney Injury or Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, double-blind, sham-controlled, multicenter, randomized clinical trial is to study the effects of remote ischemic preconditioning on contrast-associated acute kidney injury, functional capacity, and major adverse kidney events in in patients with congestive heart failure undergoing cardiac catheterization and/or percutaneous coronary intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Remote ischemic preconditioning

Trials testing the same drug.

Other recruiting trials for Acute Kidney Injury

Currently open trials in the same condition.

Other VA Office of Research and Development trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04982419.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing